Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seno appoints CMO to help launch opto-acoustic cancer imaging tech

This article was originally published in Clinica

Executive Summary

San Antonio, Texas-based Seno Medical Instruments has appointed William Keane as CMO, to spearhead the launch of its opto-acoustic imaging-based cancer detection technology, which is currently undergoing tests to support FDA approval. From this month, he will first oversee clinical studies underway at the Cancer Therapy & Research Center (part of the Texas Health Science Center), in San Antonio. In 2009, he will be responsible for launching further "pivotal trials". Dr Keane joins from Reliant Pharmaceuticals, where, as CMO, he helped the scientific/medical integration with GlaxoSmithKline.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043385

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel